measuregroup/AID322840

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103194925_AID322840_PMID17371827_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103195019_AID322840_PMID17371827_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103240599_AID322840_PMID17371827_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103245974_AID322840_PMID17371827_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103169192_AID322840_PMID17371827_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiviral activity against Lamivudine -adenofir-resistant HBV with reverse transcriptase V173L/L180M/A181V/M204V mutant
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103169192 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103245974 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103240599 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103194925 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103195019
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID322840

Total number of triples: 15.